The News Review:
- India’s Charles Correa to design `Champalimaud Centre for the…
- Genital Arousal Disorder Adversely Impacts Women’s Lives
- Gene therapy safety trial for childhood blindness under way
- Clinical trial mart to mark 15% CAGR
- Worcester Telegram & Gazette News
India’s Charles Correa to design `Champalimaud Centre for the…
TopNews – Nov 19, 2007
Charles Correa and Leonor Beleza the President of the Foundation made a presentation of their proposed design last week. The Champalimaud Research Centre will be a multidisciplinary centre for translational research of excellence with the best possible conditions to attract and retain the best researchers academics and medical doctors from Portugal and abroad in the fields of neurosciences and oncology. It will include laboratories for basic and clinical research an ambulatory care centre a vivarium an auditorium conference rooms and other teaching facilities and also an exhibition area. The state of the art facilities for basic and clinical research and for teaching will foster front line research in molecular biology genetics immunology neurosciences and behaviour and oncology as well as post-graduate and doctorate programmes and the diagnosis and treatment of neurological and cancer patients. It will be located in a beautiful site of 60000m2 in a exclusive zone of Lisbon on the waterfront of Pedrouços near the magnificent Tower of Belém. This area where the river Tagus meets the Atlantic cean is of great historical significance as the great Portuguese pioneers sailed from here to discover the ?unknown? in the XV and XVI centuries. The presence of the Champalimaud Research Centre will leverage this historical heritage by creating an inspirational link between the discoveries of yesteryear and the epic adventure of scientific research.
Genital Arousal Disorder Adversely Impacts Women’s Lives
Medical News Today – Medical News Today (press release) – Nov 19, 2007
co-author of the study. “Although no physical illness or medication showed up as a cause of PGAD in this study I would urge women to initially consult a sympathetic physician. Irwin Goldstein Editor-in-Chief of The Journal of Sexual Medicine observed “Women of all ages ranging from teens to menopause currently suffer from this obtrusive sexual problem. More research efforts to better understand and treat this unusual under-inhibited sexual condition are strongly needed. —————————-Article adapted by Medical News Today from original press release. —————————-This manuscript is published in The Journal of Sexual Medicine.
Gene therapy safety trial for childhood blindness under way
eurekalert.org – Nov 19, 2007
and his colleagues at the University of Florida began work on a virus that could safely deliver corrective genes into living animals. It’s been six years since a multi-university team used gene therapy to give sight to puppies born with a defect that causes blindness. Now the gene-transfer technique is being tested for safety in people in a phase 1 clinical research study conducted by the University of Pennsylvania and the University of Florida with support from the National Eye Institute of the National Institutes of Health. A young adult with a form of hereditary blindness called Leber congenital amaurosis type 2 or LCA2 received an injection of trillions of replacement genes into the retina of one eye this month making the volunteer one of the first people in the world to undergo the procedure.
Clinical trial mart to mark 15% CAGR
Deccan Herald – Nov 19, 2007
“Currently there are 268 approved clinical trials in India as compared to a global total of 180000. The value of the current clinical trials in India is $300-million” he said. ICRI is the country’s premier institution for clinical research and has four campuses in Mumbai Delhi Ahmedabad and Bangalore.
Worcester Telegram & Gazette News
Worcester Telegram – Worcester Telegram – Nov 19, 2007
Wendy Marsh recently joined the Department of Psychiatry at UMass Memorial Medical Center. Marsh recently completed a clinical research fellowship at Stanford. Her research and clinical work interests include bipolar disorder and women’s mental health. The UMass Memorial Children’s Medical Center recently named Dr. Francois Cachat of Shrewsbury as the new chief of pediatric nephrology.
